Cyclerion Therapeutics Inc. logo

Cyclerion Therapeutics Inc.

CYCN | NASDAQ
Chart Builder DCF Calculator
$23.52
$0.00 (0.00%)
Nov 2, 2026, 11:20 AM ET · Market open

Market Data

Market Cap
$15.73M
Enterprise Value
$14.34M
Beta
1.75
Average Volume
N/A
Shares Outstanding (Diluted)
607.29K
Shares Change YoY
38.42%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
N/A

Price Performance

Price Change 1M
-30.8%
Price Change 3M
-4.0%
Price Change 6M
1.5%
Price Change YTD
164.6%
Price Change 1Y
70.6%
Price Change 3Y
29.2%
Price Change 5Y
-93.4%
1M CAGR (ann.)
12.8%
1Y CAGR (ann.)
77.0%
5Y CAGR (ann.)
-41.1%
All-Time CAGR
-41.4%

Valuation

PE Ratio
-1.95
Forward PE
N/A
PEG Ratio
0.03
Forward PEG
0.19
PS Ratio
8.28
Forward PS
26.80
PB Ratio
3.09
P/FCF Ratio
-3.53
P/Adj. FCF Ratio
-3.36
P/OCF Ratio
-3.21
EV/Sales
7.55
EV/EBIT
-2.14
EV/EBITDA
-2.14
EV/FCF
-3.22
Earnings Yield
-51.2%
FCF Yield
-28.3%
Adj. FCF Yield
-29.7%

Financial Health

Net Cash
$1.39M
Total Debt
$0
Cash & Short-Term Investments
$1.39M
Total Assets
$6.93M
Current Ratio
0.82
Quick Ratio
0.82
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
0.00
Altman Z-Score
-53.60
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
61.6%
Operating Profit Margin
-359.2%
EBITDA Margin
-353.0%
Net Profit Margin
-353.0%
FCF Margin
-234.3%
Adj. FCF Margin
-246.2%
SBC / Revenue
11.9%
SBC Impact (per share)
-5.1%

Returns

Return on Assets
-96.8%
Return on Equity
-88.0%
Return on Invested Capital
-134.2%
Return on Capital Employed
-134.2%
Return on Tangible Assets
-96.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
70.0%
Revenue CAGR 5Y
-12.0%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
68.0%
EPS CAGR 5Y
62.9%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
56.1%
FCF CAGR 5Y
55.5%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
N/A
Analyst Count
N/A
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 11, 2026
EPS Estimate (next Q)
-$50.40
EPS Growth Est (next Q)
16700.0%
Revenue Est (next Q)
$550K
Revenue Growth Est (next Q)
-37.1%

Cash Flow

Operating Cash Flow
$-4.45M
Free Cash Flow
$-4.45M
Adj. Free Cash Flow
$-4.68M
FCF Per Share
-$7.33
OCF Per Share
-$7.33
OCF/S Ratio
-234.3%

Income Statement

Revenue
$1.9M
Gross Profit
$1.17M
Operating Income
$-6.82M
EBITDA
$-6.71M
Net Income
$-6.71M
EPS (Diluted)
-$12.04
Revenue / Employee
N/A
Profit / Employee
N/A
Employees
N/A

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.